Insider filing · ORGO

Glenn H Nussdorf bought $1.1M of Organogenesis (ORGO)

Executed May 14 2025, disclosed Nov 3 2025, 173 days later, against a two-business-day limit.

Over the 21 trading sessions from the disclosed entry session (Nov 3 2025), the stock returned +17.8% (delay-adjusted); from the execution session (May 14 2025), +1.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

GN Glenn H Nussdorf Director profile →

Glenn H Nussdorf (Director) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales, 1 filed past the two-business-day deadline), most often in ORGO. Across 1 priced purchase filing, the average 21-session return was +1.0% from execution and +17.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.5M of ORGO (287,957 sh across 2 lots, as filed), executed Nov 24 2025.

ORGO ORGO ORGO · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→